Ibaraki, Japan

Ken-ichiro Sakamoto


Average Co-Inventor Count = 6.6

ph-index = 3

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 1998-1999

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ken-ichiro Sakamoto

Introduction: Ken-ichiro Sakamoto, a notable inventor based in Ibaraki, Japan, has made significant contributions to the field of pharmaceuticals. With a total of three patents to his name, Sakamoto focuses on the development of advanced compounds that hold potential for various medicinal applications.

Latest Patents: Among his latest innovations is the "Condensed benzazepine derivative and pharmaceutical composition thereof." This invention pertains to nitrogen-containing aromatic 5-membered ring-condensed benzazepine derivatives defined by a specific chemical formula. The invention encompasses compounds that include a nitrogen-containing aromatic ring, featuring at least one nitrogen atom and options for oxygen or sulfur atoms. Further, the derivatives may have various substituents, highlighting Sakamoto's expertise in the design of complex molecular structures for therapeutic purposes.

Career Highlights: Ken-ichiro Sakamoto is currently associated with Yamanouchi Pharmaceutical Company Ltd., where he actively engages in groundbreaking research and development. His work has positioned the company at the forefront of medicinal innovation, significantly impacting patient care through novel pharmaceutical solutions.

Collaborations: Throughout his career, Sakamoto has collaborated with fellow researchers Nobuaki Taniguchi and Akihiro Tanaka. Together, they have contributed to a wealth of knowledge in the pharmaceutical chemistry sector, further enhancing the efficacy of their inventions and promoting collaborative innovation.

Conclusion: Ken-ichiro Sakamoto's role as an inventor in the pharmaceutical industry exemplifies the importance of innovative thinking in developing new therapeutic agents. With his ongoing contributions and successful collaborations, Sakamoto continues to make strides in advancing medical science, benefitting both the industry and patient communities alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…